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Osteopetrosis, or marble bone 
disease, is a disturbance of skeletal 
development in which the rate of 
bone resorption fails to keep pace 
with the rate of bone formation. 
Bone matrix accumulates exces-
sively throughout the skeletal sys-
tem, causing damage to neighbor-
ing tissues-particularly the dental, 
hematopoietic and nervous tissues. 
The line of investigation on 
osteopetrosis which has led to the 
current point of view that the thy-
roid gland represents the primary 
site of the disturbance was initiated 
soon after an experimental animal 
became available. In 1935 Hans 
Grlineberg described a mutant of 
the house mouse, named the grey-
lethal , whose skele tal system 
showed manifestations of osteope-
trosis which closely resembled 
those in man originally described 
by Albers-Schonberg in 1904. 
Barnicot (1948), working at Uni-
versity College, was the first to 
show that osteopetrosis is an endo-
crine disorder. His most interesting 
work involved the reciprocal trans-
plantation of parathyroid tissue and 
bone. In one experiment he took 
from a grey-lethal mouse a piece of 
calvarial bone and a parathyroid 
body, attached the gland to the 
surface of the bone, and implanted 
the graft intracerebrally in a normal 
sibling. A few days later, when the 
graft was removed for examination, 
the calvarial bone was found to 
have been perforated in the region 
underlying the parathyroid gland. 
When the grey-lethal mouse was 
used as host for grafting a parathy-
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roid body and bone obtained from 
a normal littermate, little or no evi-
dence of bone erosion was demon-
strable at the end of the culture 
period. 
In another experiment (Barnicot, 
1941) , ribs from a grey-lethal 
mouse were transplanted into a 
normal littermate. When exam-
ined histologically two weeks later, 
the rib grafts appeared normal. 
In the reciprocal transplantation, 
in which a rib from a normal 
mouse was cultured subcutaneously 
in a grey-lethal littermate, the graft 
underwent osteopetrotic changes. 
From these results it was evident 
that the failure of bone remodelling 
in the osteopetrotic mouse was not 
explicable on the basis of incompe-
tence on the part of either osteo-
clasts or the chief cells of the para-
thyroid gland. In an effort to 
promote the resorption of the ex-
cess bone, Barnicot ( 1945) dis-
covered that the grey-lethal mouse 
suffered no ill effects from repeated 
injections of parathyroid extract 
(PTE) at a dose level that was 
toxic enough to kill the normal 
siblings after only one exposure. 
Thus, Barnicot terminated his study 
of the grey-lethal mouse by sug-
gesting that osteopetrosis is a form 
of hypoparathyroidism which can-
not be cured by parathormone 
therapy alone. 
There are two reasons why the 
"hypoparathyroid hypothesis" is 
not tenable. It has long been known 
that normal mice which have been 
thyroparathyroidectomized at birth 
do not develop osteopetrosis. Fur-
thermore, the fact that bone ero-
sion failed to occur, even when the 
parathyroid body was in direct con-
tact with the calvarial bone, rules 
out the possibility that a parathor-
mone-destroying tissue intervenes 
between the gland and its target. 
In seeking additional information 
as a basis for an alternative to 
Barnicot's explanation, I first de-
voted my efforts to measuring the 
plasma calcium concentration in 
untreated animals of both sexes at 
various ages. All of the grey-lethals 
examined, including the younger 
well-nourished group, were found 
to be hypocalcemic, with a total 
plasma calcium averaging 20 % be-
low the mean value of plasma cal-
cium obtained from the normal 
littermates. In response to a single 
injection of PTE at a dosage of 
5 units/ gm of body weight, the 
plasma calcium level of normal 
mice one to four weeks of age 
increased by 100% in 18 hours 
and 200 % in 36 hours. Grey-lethal 
mice given the same dosage of 
PTE showed a maximum elevation 
of plasma calcium concentration of 
only 25 % , reached within 18 
hours. By 36 hours the plasma cal-
cium fell to a tetanic threshold 
level. In response to injections of 
PTE administered at intervals of 
12 hours for as long as eight days, 
the grey-lethal mouse never be-
came hypercalcemic, whereas the 
normal littermates invariably died 
by the second or third day with 
extreme hypercalcemia and nephro-
calcinosis. 
In an effort to locate the basis 
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for the great resistance to parathy-
roid hormone observed in the grey-
lethal, a thorough cytological and 
histochemical assessment of osteo-
clasts was conducted. Bone samples 
obtained from grey-lethals between 
12 and 24 hours after the admin-
istration of parathormone showed 
widespread or intense signs of os-
teoclastic activity, including an ex-
ceptionally high level of collagen-
ase (Walker, l 966a). However, in 
the untreated mice and at all time 
points later than 24 hours in the 
parathormone-treated animals, os-
teolytic activity was subnormal, 
whereas the signs of increased os-
teoblastic activity were most im-
pressive . The endosteum was hyper-
plastic, containing several layers 
of osteoprogenitor cells as well as 
a prominent layer of large osteo-
blasts; adjacent to the endosteum 
was a thick seam of osteoid. The 
hyperplastic endosteum was dis-
tributed over most of the trabecular 
surface in the grey-lethal bones. In 
order to place the osteogenic eval-
uation on a quantitative basis, I 
employed tritiated proline incor-
poration studies. Tritiated proline 
was administered intraperitoneally 
at a dosage of 4µ,c to 8µ,c per 
gm of body weight, and the animal 
was sacrificed six hours later. 
Samples of calvarial and tibial bone 
were pulverized, extracted in ether, 
suspended in scintillation fluid and 
counted by means of a well-type 
automated scintillation counter. The 
counts obtained from the untreated 
animals indicated that the grey-
lethal incorporated 50 % more of 
the 3H-proline into bone matrix 
than the normal control. Parathy-
roid hormone was found to depress 
incorporation in the normal by 
about 50 % but in the grey-lethal 
by only about 15% (Walker, 
1966b). 
According to our interpretation 
of the results of the evaluation of 
osteolytic and osteogenic activities 
in the osteopetrotic mouse, the im-
balance leading to the excessive ac-
cumulation of bone is more likely 
to be due to increased osteoblastic 
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activity than to decreased osteo-
clastic activity. In attempting to 
locate an abnormally enlarged 
source of an osteoblastic-stimulat-
ing factor, the pituitary and thyroid 
glands were surveyed thoroughly 
by means of light and electron mi-
croscopy. No evidence of increased 
somatotroph or follicle cell activi-
ties was disclosed ; however, a 
parafollicular cell hyperplasia was 
discovered in the parathormone-
treated grey-lethals. In electron mi-
crographs the parafollicular cell 
differs from the follicle cell in 
several respects. It is of a larger 
size, has a shape that is oval instead 
of polygonal, and occupies a more 
peripheral (parafollicular) posi-
tion, resting against the basement · 
membrane of the follicle but never 
bordering directly on the colloid. 
Unlike all other epithelial cells, the 
parafollicular cells are devoid of 
intercellular attachment devices, 
such as desmosomes, light junc-
tions, and interlocking processes. 
The most distinctive feature of the 
parafollicular cells is the abundance 
of cytoplasmic secretory vesicles. 
These vesicles are about 0.2µ, in 
diameter and appear to be empty 
but may contain thyrocalcitonin, 
a substance of homogeneous ap-
pearance and low electron opacity. 
Since the parafollicular cell has 
been shown to be the source of 
thyrocalcitonin, the presence of a 
parafollicular cell hyperplasia may 
represent an excessive capacity to 
produce thyrocalcitonin. Chronic 
hypercalcitoninemia would be as-
sociated with sustained hypocal-
cemia, hypophosphatemia, and a 
retardation of bone resorption. All 
of these signs are characteristic of 
osteopetrosis as manifested in the 
grey-lethal mouse. The increased 
rate of bone formation observed in 
the grey-lethal might indicate that 
thyrocalcitonin has a dual action on 
bone-inhibiting osteolytic activity, 
yet stimulating osteogenic activity 
-a combination of effects di-
ametrically opposed to the effects of 
parathormone. 
In addition to the grey-lethal, 
three other mutants with osteope-
trosis have recently been studied. 
The implication of the findings ob-
tained in microphthalmic and os-
teosclerotic mice is essentially the 
same as the implication of the find-
ings obtained from the grey-lethal 
(S. C. Marks and D. G. Walker, 
unpublished data) . 
Rabbits with hereditary osteope-
trosis as well as the mice with con-
genital osteopetrosis are hypocal-
cemic throughout life. They fail 
to develop hypercalcemia even 
when placed on an intensive para-
thormone regimen. However, the 
abnormal tolerance · to parathor-
mone in the rabbit does not seem 
to be related to parafollicular cell 
activity, as it was in osteopetrotic 
mice. The parafollicular cell popu-
lation is not elevated in the rabbits, 
and, even after thyroidectomy or 
thyroparathyroidectomy, the osteo-
petrotic rabbits are refractory to 
the influence of parathormone. Fur-
thermore, the rabbit mutants never 
show increased osteogenic activity; 
in fact, according to tritiated pro-
line incorporating studies carried 
out at various ages from birth to 
one month of age, their capacity to 
make bone matrix is only about 
half that of the normal littermates. 
Osteopetrotic rabbit bones show re-
duced numbers of osteoblasts, os-
teoclasts of abnormal appearance 
and an abundance of mesenchyme 
throughout the intertrabecular 
spaces (D. G. Walker and R. R. 
Fox, unpublished data) . 
On the basis of the fragmentary 
data available at present, the pri-
mary defect in hereditary osteo-
petrosis of the rabbit appears to be 
located in osseous tissue rather 
than in the endocrine system. 
Recently, osteopetrosis has been 
induced in normal mice (S. C. 
Marks, unpublished data), rabbits 
and rats (D. G . Walker and M.A. 
Shepp, unpublished data) by means 
of daily injections of PTE at the 
moderately low dose level of 0.5 
units/ gm of l:\ody weight. Through-
out the two-week or longer PTE 
regimen initiated at birth, the med-
ullary cavities of the long bones 
failed to enlarge, and the cancel-
lous bone of the epiphyses and me-
taphyses became increasingly dense, 
gradually approaching compact 
bone in appearance. The experi-
mentally osteopetrotic animals, like 
the congenitally osteopetrotic mice, 
showed increased extent of osteo-
blastic activity in autoradiographic 
studies and elevated levels of triti-
ated proline incorporation into bone 
matrix as determined by counting 
of radioactivity. In general, the 
counts indicated that the experi-
mental animals incorporated two 
to three times as much of the ad-
ministered label as did their normal 
littermate controls. In addition, 
parafollicular cell hyperplasia was 
shown to exist in all of the animals 
with induced osteopetrosis. The 
parafollicular cell population in the 
experimental animals was increased 
about eightfold over that of the 
controls. 
The explanation for the mecha-
nism which induced osteopetrosis in 
normal mice was as follows. The 
daily injection of PTE caused a 
transient hypercalcemia. This, in 
turn, stimulated the secretory and 
proliferative activities of the para-
follicul ar cells, leading to an over-
production of thyrocalcitonin. The 
explanation received additional sup-
port from the finding that osteo-
petrosis could not be induced in 
mice that had been completely 
thyroidectomized. In those instances 
where the thyroidectomy was not 
complete, the degree of osteope-
trosis induced by the parathormone 
regimen correlated directly with 
the number of parafollicular cells 
counted in the remnant of thyroid 
gland (S. C. Marks and D . G. 
Walker, unpublished data). 
From these investigations on 
hereditary and induced osteope-
trosis has emerged the theory that 
the parafollicular cell is the source 
of a potent osteoblast-stimulating 
factor which may be an entity dis-
tinct from thyrocalcitonin. Accord-
ing to general consensus, thyrocal-
citonin has but one action, namely, 
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inhibiting bone resorption. There-
fore, at the present time we are in-
vestigating other possible sources 
for the osteoblast-stimulating influ-
ence. In order to determine whether 
or not the growth-promoting effect 
was mediated by the pituitary gland, 
rats hypophysectomized at two 
weeks of age were injected with 
either growth hormone or PTE or a 
combination of the two hormones 
for a period of three weeks. As 
compared with the untreated hypo-
physectomized controls, hormone-
injected hypophysectomized rats 
showed approximately a tenfold in-
crease in the number of parafollic-
ular cells of the thyroid gland 
and a threefold to fivefold increase 
in the bone label-incorporating ca-
pacity. The excessive accumulation 
of bone matrix was observed only 
in those animals receiving PTE, 
but the . osteopetrotic trend devel-
oped more rapidly in animals re-
ceiving growth hormone in addi-
tion to PTE. The disturbance of 
calcium homeostasis that leads to 
the excessive accumulation of bone 
matrix occurs not only when the 
endogenous source of parathor-
mone is inhibited, but also when 
thyrocalcitonin production is in-
creased. This dual effect is created 
by the administration of PTE at a 
low dose level. However, adminis-
tration of growth hormone indi-
rectly stimulates the activities of 
the chief cell of the parathyroid 
gland as well as the parafollicular 
cell of the thyroid and, thus, cal-
cium homeostasis is not disturbed . 
The fact that growth hormone acts 
synergistically with PTE in pro-
ducing osteopetrosis can be ex-
plained simply by the fact that 
growth hormone stimulates chon-
drogenesis, and the more rapid the 
rate of cartilage production by the 
epiphyseal plate, the more rapid 
the bone accumulation under con-
ditions where bone resorption has 
been inhibited. 
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